Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Journal of Chromatographic Science
|
January 24, 2024
An Eco-Friendly RP-HPLC Method Development and Validation for Quantification of Favipiravir in Bulk and Tablet Dosage Form Followed by Forced Degradation Study
Monika B Sangani, Nirav Patel
JAMA
|
June 22, 1999
Autopsy rates and diagnosis
B Sangani, V Kalyanaraman, M Bhargava, et al.
Current Opinion in Psychiatry
|
December 6, 2017
Current developments in the genetics of Rett and Rett-like syndrome
Friederike Ehrhart, Nasim B Sangani, Leopold M G Curfs
East African Medical Journal
|
March 1, 1995
Retrospective study of alleged sexual assault at the Aga Khan Hospital, Nairobi
S Chaudhry, B Sangani, S B Ojwang, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 18, 2014
Schiff's base derivatives bearing nitroimidazole and quinoline nuclei: new class of anticancer agents and potential EGFR tyrosine kinase inhibitors
Jigar A Makawana, Chetan B Sangani, Lin Lin, et al.
Current Topics in Medicinal Chemistry
|
June 5, 2019
New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics
Yong-Tao Duan, Chetan B Sangani, Wei Liu, et al.
Bioorganic Chemistry
|
October 5, 2023
A novel class of pyrazole analogues as aurora kinase A inhibitor: design, synthesis, and anticancer evaluation
Digambar B Yevale, Nishith Teraiya, Twinkle D Lalwani, et al.
Chemico-Biological Interactions
|
July 13, 2025
Novel anticancer inhibitors targeting the PI3K/Akt/mTOR signaling route and apoptosis inducers: A study on the apoptosis mechanism via the intrinsic mitochondrial-mediated pathway
Digambar Yevale, Viralkumar Buha, Deepkumar U Sangani, et al.
European Journal of Medicinal Chemistry
|
March 11, 2014
Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents
Chetan B Sangani, Jigar A Makawana, Xin Zhang, et al.
Bioorganic Chemistry
|
September 26, 2024
Novel purine derivatives as selective CDK2 inhibitors with potential anticancer activities: Design, synthesis and biological evaluation
Alpesh Shah, Nishith Teraiya, Jignesh H Kamdar, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Journal of Chromatographic Science
|
January 24, 2024
An Eco-Friendly RP-HPLC Method Development and Validation for Quantification of Favipiravir in Bulk and Tablet Dosage Form Followed by Forced Degradation Study
Monika B Sangani, Nirav Patel
JAMA
|
June 22, 1999
Autopsy rates and diagnosis
B Sangani, V Kalyanaraman, M Bhargava, et al.
Current Opinion in Psychiatry
|
December 6, 2017
Current developments in the genetics of Rett and Rett-like syndrome
Friederike Ehrhart, Nasim B Sangani, Leopold M G Curfs
East African Medical Journal
|
March 1, 1995
Retrospective study of alleged sexual assault at the Aga Khan Hospital, Nairobi
S Chaudhry, B Sangani, S B Ojwang, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 18, 2014
Schiff's base derivatives bearing nitroimidazole and quinoline nuclei: new class of anticancer agents and potential EGFR tyrosine kinase inhibitors
Jigar A Makawana, Chetan B Sangani, Lin Lin, et al.
Current Topics in Medicinal Chemistry
|
June 5, 2019
New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics
Yong-Tao Duan, Chetan B Sangani, Wei Liu, et al.
Bioorganic Chemistry
|
October 5, 2023
A novel class of pyrazole analogues as aurora kinase A inhibitor: design, synthesis, and anticancer evaluation
Digambar B Yevale, Nishith Teraiya, Twinkle D Lalwani, et al.
Chemico-Biological Interactions
|
July 13, 2025
Novel anticancer inhibitors targeting the PI3K/Akt/mTOR signaling route and apoptosis inducers: A study on the apoptosis mechanism via the intrinsic mitochondrial-mediated pathway
Digambar Yevale, Viralkumar Buha, Deepkumar U Sangani, et al.
European Journal of Medicinal Chemistry
|
March 11, 2014
Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents
Chetan B Sangani, Jigar A Makawana, Xin Zhang, et al.
Bioorganic Chemistry
|
September 26, 2024
Novel purine derivatives as selective CDK2 inhibitors with potential anticancer activities: Design, synthesis and biological evaluation
Alpesh Shah, Nishith Teraiya, Jignesh H Kamdar, et al.
Page
of 2